scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.YGYNO.2012.07.001 |
P698 | PubMed publication ID | 22800653 |
P50 | author | Jesper Hallas | Q43490380 |
P2093 | author name string | Jørn Herrstedt | |
Merete Paludan | |||
Laurids Østergaard Poulsen | |||
Anni Young Stensgård Jørgensen | |||
Karin Herskind Bruun | |||
Sandra Teiblum | |||
Trine Lembrecht Jørgensen | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
ASA physical status classifications: a study of consistency of ratings | Q28276157 | ||
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group | Q31962966 | ||
Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results | Q33332312 | ||
Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer. | Q33333839 | ||
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study | Q33348987 | ||
Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database. | Q33420943 | ||
Single agents should be administered in preference to combination chemotherapy for the treatment of patients over 70 years of age with advanced ovarian carcinoma. | Q33900899 | ||
Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly | Q35214119 | ||
Ovarian cancer in younger vs older women: a population-based analysis | Q36611969 | ||
Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study | Q36760924 | ||
Comprehensive geriatric assessment for older patients with cancer | Q36815525 | ||
Older female cancer patients: importance, causes, and consequences of undertreatment | Q36815538 | ||
Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study | Q36912591 | ||
Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply? | Q37169893 | ||
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference | Q37872164 | ||
Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale for High-Age Patients (CRASH) score | Q39688507 | ||
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer | Q40673230 | ||
The Danish Cancer Registry | Q45848855 | ||
The Danish Register of Causes of Death. | Q50554191 | ||
Survival and prognostic factors in patients with ovarian cancer | Q53301800 | ||
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer | Q57903823 | ||
Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience | Q57904796 | ||
GRADING OF PATIENTS FOR SURGICAL PROCEDURES | Q62567994 | ||
Feasibility, toxicity and quality of life of first-line chemotherapy with platinum/paclitaxel in elderly patients aged >or=70 years with advanced ovarian cancer--a study by the AGO OVAR Germany | Q79326663 | ||
Ovarian cancer in the elderly: feasibility of surgery and chemotherapy in 89 geriatric patients | Q79797677 | ||
Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients | Q80665192 | ||
The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study | Q81574365 | ||
Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring individualization | Q84602056 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ovarian cancer | Q172341 |
comorbidity | Q1414874 | ||
adherence (medicine) | Q67004728 | ||
P304 | page(s) | 367-374 | |
P577 | publication date | 2012-07-16 | |
P1433 | published in | Gynecologic Oncology | Q5625182 |
P1476 | title | Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients | |
P478 | volume | 127 |